ArticleCancer letters2025
Corrigendum to "Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer" [Cancer Lett. 2023 Dec 1;578:216437].
Samrita Dogra et al.PubMed ↗Publisher ↗
No numbers read from the abstract.